Neoadjuvant Immune Checkpoint Blockade Before Chemoradiation for Patients with FIGO Stage IB3–IVA Cervical Squamous Carcinoma: GINECO Window-Of-Opportunity COLIBRI Study

Combining immune checkpoint blockade (ICB) with chemoradiation is effective in locally advanced cervical cancer. However, the impact of dual ICB before any therapy on immune modulation and treatment response is poorly understood. Overall design: Targeted gene expression profiling of 2549 genes was performed using HTG sequencing at three timepoints